The major limitations of drug risk assessments based on electronic #health data. http://t.co/G5HPi7gRJd #pharma
Interesting article about the lack of results, limitations, and biases in @US_FDA #Sentinel program by @ISMP1 http://t.co/NHQilRu3M1
Interesting article about the lack of results, limitations, and biases in @US_FDA #Sentinel program by @ISMP1 http://t.co/NHQilRu3M1
Interesting article about the lack of results, limitations, and biases in @US_FDA #Sentinel program by @ISMP1 http://t.co/NHQilRu3M1
Interesting article about the lack of results, limitations, and biases in @US_FDA #Sentinel program by @ISMP1 http://t.co/NHQilRu3M1
Interesting article about the lack of results, limitations, and biases in @US_FDA #Sentinel program by @ISMP1 http://t.co/NHQilRu3M1
Interesting article about the lack of results, limitations, and biases in @US_FDA #Sentinel program by @ISMP1 http://t.co/NHQilRu3M1
Historia clínica electrónica para vigilancia post-venta. Un expectativa excesiva para seguir los daños x medicamentos http://t.co/rzgkETZujE
Historia clínica electrónica para vigilancia post-venta. Un expectativa excesiva para seguir los daños x medicamentos http://t.co/rzgkETZujE
Historia clínica electrónica para vigilancia post-venta. Un expectativa excesiva para seguir los daños x medicamentos http://t.co/rzgkETZujE
Historia clínica electrónica para vigilancia post-venta. Un expectativa excesiva para seguir los daños x medicamentos http://t.co/rzgkETZujE
Electronic health data for postmarket surveillance. A vision not realized. Harms of drugs, and EMR. Too much expected http://t.co/rzgkETZujE
I'm reading Electronic Health Data for Postmarket Surveillance: A Vision Not Realized http://t.co/utgXpaWQ9x #springerlink
Electronic Health Data for Postmarket Surveillance: A Vision Not Realized http://t.co/E7cHnequ6c #PtSafety